Build a lasting personal brand

MindBio Therapeutics Expands AI Voice Platform with Fatigue Detection Module for Workplace Safety

By Advos
MindBio Therapeutics is adding fatigue prediction to its AI voice analytics platform, aiming to enhance safety in high-risk industries through non-invasive detection of impairment.

Found this article helpful?

Share it with your network and spread the knowledge!

MindBio Therapeutics Expands AI Voice Platform with Fatigue Detection Module for Workplace Safety

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is broadening the scope of its AI-driven voice technology platform with the development of a fatigue prediction model designed for high-risk workplace environments. The company announced May 11 that it has developed a fatigue recognition system using speech analytics and proprietary artificial intelligence models, according to a news release (https://ibn.fm/4KNzG).

MindBio has filed a patent application covering detection of neurologically active substances and fatigue through voice analysis. The fatigue detection capability is expected to become an additional feature within MindBio’s planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of drug and alcohol impairment. The company says commercial testing of the kiosk hardware and software remains on track for late Q2 2026.

Management is positioning the technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing systems. The initial sectors targeted for deployment include mining, aviation, transportation and construction—industries where impairment and fatigue pose significant safety risks.

“The addition of fatigue detection to our platform addresses a critical need in workplace safety,” said a company representative. By analyzing voice patterns, the system can potentially identify signs of fatigue before they lead to accidents, complementing existing intoxication screening.

The expansion comes as MindBio continues to commercialize its AI voice technology for drug and alcohol intoxication detection. The company believes that combining fatigue detection with impairment screening in a single kiosk could offer employers a comprehensive safety solution.

For investors, the development signals MindBio’s commitment to broadening its technology’s applications beyond initial use cases. The company’s newsroom (https://ibn.fm/MBQIF) provides updates on MBQIF stock and corporate developments.

The fatigue prediction module will be added to the Edge AI Intoxication Detection Kiosks, which are being developed for industrial workplaces. MindBio’s approach leverages proprietary AI models trained on speech data to detect subtle changes associated with fatigue and intoxication.

This announcement matters because workplace fatigue is a major contributor to accidents in high-risk industries. Traditional testing methods are often invasive or require laboratory analysis. MindBio’s non-invasive voice-based system could improve compliance and enable real-time monitoring, potentially reducing incidents and saving lives. The integration of fatigue detection also broadens the platform’s appeal to safety-conscious employers seeking a single tool for multiple impairment risks.

Advos

Advos

@advos